Correlation Between Pasithea Therapeutics and AN2 Therapeutics
Can any of the company-specific risk be diversified away by investing in both Pasithea Therapeutics and AN2 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pasithea Therapeutics and AN2 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pasithea Therapeutics Corp and AN2 Therapeutics, you can compare the effects of market volatilities on Pasithea Therapeutics and AN2 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pasithea Therapeutics with a short position of AN2 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pasithea Therapeutics and AN2 Therapeutics.
Diversification Opportunities for Pasithea Therapeutics and AN2 Therapeutics
-0.45 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Pasithea and AN2 is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Pasithea Therapeutics Corp and AN2 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AN2 Therapeutics and Pasithea Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pasithea Therapeutics Corp are associated (or correlated) with AN2 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AN2 Therapeutics has no effect on the direction of Pasithea Therapeutics i.e., Pasithea Therapeutics and AN2 Therapeutics go up and down completely randomly.
Pair Corralation between Pasithea Therapeutics and AN2 Therapeutics
Given the investment horizon of 90 days Pasithea Therapeutics Corp is expected to generate 0.82 times more return on investment than AN2 Therapeutics. However, Pasithea Therapeutics Corp is 1.21 times less risky than AN2 Therapeutics. It trades about -0.04 of its potential returns per unit of risk. AN2 Therapeutics is currently generating about -0.09 per unit of risk. If you would invest 605.00 in Pasithea Therapeutics Corp on November 5, 2024 and sell it today you would lose (393.00) from holding Pasithea Therapeutics Corp or give up 64.96% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 99.59% |
| Values | Daily Returns |
Pasithea Therapeutics Corp vs. AN2 Therapeutics
Performance |
| Timeline |
| Pasithea Therapeutics |
| AN2 Therapeutics |
Pasithea Therapeutics and AN2 Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pasithea Therapeutics and AN2 Therapeutics
The main advantage of trading using opposite Pasithea Therapeutics and AN2 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pasithea Therapeutics position performs unexpectedly, AN2 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AN2 Therapeutics will offset losses from the drop in AN2 Therapeutics' long position.| Pasithea Therapeutics vs. Nutriband Warrant | Pasithea Therapeutics vs. MediciNova | Pasithea Therapeutics vs. Virax Biolabs Group | Pasithea Therapeutics vs. Revelation Biosciences |
| AN2 Therapeutics vs. Aerovate Therapeutics | AN2 Therapeutics vs. Adagene | AN2 Therapeutics vs. Acrivon Therapeutics, Common | AN2 Therapeutics vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |